Characterization of the anti-inflammatory capacity of IL-10-producing neutrophils in response to Streptococcus pneumoniae Infection
Artículo
Access note
Acceso abierto
Publication date
2021Metadata
Show full item record
Cómo citar
González, Liliana A.
Cómo citar
Characterization of the anti-inflammatory capacity of IL-10-producing neutrophils in response to Streptococcus pneumoniae Infection
Author
- González, Liliana A.;
- Melo González, Felipe;
- Sebastián, Valentina P.;
- Vallejos, Omar P.;
- Noguera, Loreani P.;
- Suazo, Isidora D.;
- Schultz Lombardic, Barbara Melinka;
- Manosalva, Andrés H.;
- Peñaloza, Hernán F.;
- Soto, Jorge A.;
- Parker, Dane;
- Riedel, Claudia A.;
- González, Pablo A.;
- Kalergis, Alexis M.;
- Bueno, Susan M.;
Abstract
Neutrophils are immune cells classically defined as pro-inflammatory effector cells.
However, current accumulated evidence indicates that neutrophils have more versatile
immune-modulating properties. During acute lung infection with Streptococcus
pneumoniae in mice, interleukin-10 (IL-10) production is required to temper an
excessive lung injury and to improve survival, yet the cellular source of IL-10 and the
immunomodulatory role of neutrophils during S. pneumoniae infection remain unknown.
Here we show that neutrophils are the main myeloid cells that produce IL-10 in the lungs
during the first 48 h of infection. Importantly, in vitro assays with bone-marrow derived
neutrophils confirmed that IL-10 can be induced by these cells by the direct recognition of
pneumococcal antigens. In vivo, we identified the recruitment of two neutrophil
subpopulations in the lungs following infection, which exhibited clear morphological
differences and a distinctive profile of IL-10 production at 48 h post-infection.
Furthermore, adoptive transfer of neutrophils from WT mice into IL-10 knockout mice
(Il10-/-) fully restored IL-10 production in the lungs and reduced lung histopathology.
These results suggest that IL-10 production by neutrophils induced by S. pneumoniae
limits lung injury and is important to mediate an effective immune response required for
host survival.
Patrocinador
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)
CONICYT FONDECYT 1170964
1190830
1191300
1190864
ANID-Millenium Science Initiative Program: Millenium Institute on Immunology and Immunotherapy ICN09_016
P09/016-F
Agencia Nacional de Investigacion y Desarrollo 21150853
INNOVACORFO program of Chilean Ministry of Economy 13CTI-21526 P5
Innovation Fund for Competitiveness FIC-R 2017 from the NIH 30488811-0
R01HL134870
Pilot Project Program in Hemostasis and Vascular Biology (P3HVB), University of Pittsburgh Vascular Medicine Institute
Hemophilia Center of Western Pennsylvania
Institute for Transfusion Medicine
Indexation
Artículo de publícación WoS
Quote Item
Frontiers in Immunology April 2021 Volume 12 Article 638917
Collections
The following license files are associated with this item: